Randomized controlled trial of asthma risk with paracetamol use in infancy - a feasibility study
Author:
Affiliation:
1. Medical Research Institute of New Zealand; Wellington New Zealand
2. Capital and Coast District Health Board; Wellington New Zealand
3. University of Otago; Wellington New Zealand
4. The University of Auckland; Auckland New Zealand
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12433/fullpdf
Reference45 articles.
1. The asthma epidemic;Eder;N Engl J Med,2006
2. Prevalence and etiology of asthma;Beasley;J Allergy Clin Immunol,2000
3. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy,2004
4. The association of acetaminophen and asthma prevalence and severity;McBride;Pediatrics,2011
5. The acetaminophen and asthma hypothesis 10 years on: a case to answer;Farquhar;J Allergy Clin Immunol,2009
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The association between ibuprofen administration in children and the risk of developing or exacerbating asthma: a systematic review and meta-analysis;BMC Pulmonary Medicine;2024-08-26
2. The association between ibuprofen administration in children and the risk of developing or exacerbating asthma: a systematic review and meta-analysis;2023-10-27
3. Adherence rates during a randomized controlled trial evaluating the use of blinded acetaminophen and ibuprofen in children with asthma;Contemporary Clinical Trials;2021-05
4. Randomised controlled trial of paracetamol or ibuprofen, as required for fever and pain in the first year of life, for prevention of asthma at age 6 years: paracetamol or ibuprofen in the primary prevention of asthma in Tamariki (PIPPA Tamariki) protocol;BMJ Open;2020-12
5. The potential role of pharmacogenomics and biotransformation in hypersensitivity reactions to paracetamol;Current Opinion in Allergy & Clinical Immunology;2018-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3